vIRF1 and vIRF3 are expressed during the latent phase, and suppression of USP7 DUB activity is critical to inhibit p53 tumor suppressor activity and enable efficient replication of KSHV latently infected cells. The gene discussed is TP53; the disease is neoplasm.